)
Legacy Education (LGCY) investor relations material
Legacy Education Q1 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q1 FY2027 revenue rose 3.1% YoY to $20.0M; enrollment reached a record 3,684, up 5.4% YoY, with 1,006 new starts.
Net income fell 60.3% to $0.9M amid growth investments, higher costs, and a $687,500 estimated legal settlement.
Financial highlights
Revenue was $20.0M versus $19.4M a year ago; operating income was $0.9M versus $2.7M, or $1.6M excluding the settlement.
Net income was $0.9M versus $2.2M; diluted EPS was $0.06 versus $0.16. Excluding the settlement, net income was $1.4M and diluted EPS was $0.10.
Educational services expense rose 13.0% to $11.7M; G&A rose 18.2% to $7.2M, including the estimated settlement.
EBITDA was $1.1M versus $2.8M; adjusted EBITDA was $2.1M versus $3.1M.
Operating cash flow was negative $0.9M versus positive $1.1M YoY; capital expenditures were $0.2M in both periods.
Outlook and guidance
FY2027 priorities include growing starts while maintaining admission standards, launching approved programs, filling added capacity, and aligning spending with enrollment and cash generation.
Houston campus opening is planned before Dec. 31, 2026, subject to regulatory and accreditation approvals; management targeted 300 starts by July 1, subject to approvals and launch timing.
Contra Costa plans to launch approved Cardiac Sonography, MRI, and Veterinary Assistant programs in H2 FY2027.
Liquidity is expected to fund operations, planned capex, and working capital for at least 12 months.
- Six director nominees and the FY2027 auditor appointment go before shareholders.LGCY
Proxy filing - Six directors and the auditor face votes at a virtual Dec. 15, 2026 meeting.LGCY
Proxy filing - Achieved 33% revenue and 45% enrollment growth in 2024, driven by healthcare program expansion.LGCY
Investor presentation - Record revenue, margin, and enrollment gains set the stage for growth via new programs and expansion.LGCY
Q4 2026 - 32% revenue growth and strong student outcomes drive expansion in accredited healthcare education.LGCY
Investor presentation - Q3 2026 revenue up 15% and net income up 7.5%, driven by enrollment and new programs.LGCY
Q3 2026 - Achieved 42% revenue growth and 17% enrollment growth, with strong student outcomes and robust liquidity.LGCY
Investor presentation - Q2 revenue up 40.7% and net income up 46%, driven by enrollment and acquisition growth.LGCY
Q2 2026 - Q3 revenue rose 50.7% and enrollment 49.8%, driven by CCMCC acquisition and strong demand.LGCY
Q3 2025
)
)
)
)
)
)
)
)